# RINGSIDE (NCT04871282)

> A Study of AL102 in Patients With Progressing Desmoid Tumors

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04871282
- Phase: PHASE2, PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Immunome, Inc.
- Conditions: Desmoid; Desmoid Tumor
- Interventions: AL102; Placebo
- Enrollment: 198
- Primary outcome: Part A: Safety and Tolerability - Adverse Events
- Primary outcome: Part B: Progression free survival (PFS)

## Commentary we found

- YouTube: 14
- Podcasts: 10
- X threads: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=ringside-nct04871282

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04871282", "email": "<work email>"}; the inbox owner confirms by the emailed link.